TITLE:
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)

CONDITION:
Osteoarthritis

INTERVENTION:
MK0966, rofecoxib

SUMMARY:

      The purpose of this study is to compare the safety and effectiveness of two approved drugs
      in the treatment of osteoarthritis of the knee.
    

DETAILED DESCRIPTION:

      The duration of treatment is 6 weeks.
    

ELIGIBILITY:
Gender: All
Age: 40 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Osteoarthritis of the knee which requires treatment with medication for pain relief

        Exclusion Criteria:

          -  Any known allergy to the study drugs
      
